The Latest News

03.26.2013 | Corporate, EZIO | News | San Antonio, TX

Vidacare Corporation has launched a free point-of-care app for health care professionals to answer clinical and training questions related to its EZ-IO® Intraosseous Vascular Access System. The app is now available for download at the Apple iTunes Store and features interactive guides, videos and instructions on using the EZ-IO to obtain intraosseous vascular access.

The EZ-IO mobile app was designed to serve as a quick reference guide on how to obtain vascular access using the intraosseous (inside the bone) space. In a matter of seconds, users can reference relevant information about the EZ-IO including guidance on insertion sites, needle selection, needle insertion and removal, pain management and warnings and precautions. It is currently available for iPhones and iPads, with versions for other types of smart phones anticipated in late 2013.

The EZ-IO® Intraosseous Vascular Access System is the first battery-powered device to establish immediate intraosseous vascular access, and is used by 90 percent of US advanced life support ambulances, over half of US hospital Emergency Departments, and the US Military.

Established in 2001, Vidacare Corporation is the pioneer of a broad technology platform for accessing the intraosseous (inside the bone) space. Current products include the EZ-IO® System, the OnControl® Bone Marrow System and the OnControl® Bone Access System. Applications include vascular access, emergency and disaster medicine, hematology/oncology and spinal procedures. Privately held, the company is based in San Antonio, Texas, and its products are marketed in over 50 countries worldwide.

TULLIS HEALTH INVESTORS INC.

The firm was founded in 1986 by Jim Tullis, a leading health care investment banker and 14-time Institutional Investor All-Star. Under his leadership, the Tullis family of funds has been investing successfully and exclusively in privately held health care companies through several funds for over 30 years. Considered a pioneer in healthcare focused venture and growth capital, the team invests in all major areas of the healthcare industry. US-based, with an office in North Palm Beach, Florida, the firm also has international operations including a presence in Beijing. The team combines extensive operating and clinical experience in the US and globally, with a strong history of successful health care private equity investing.

Investment Approach

Tullis provides equity and equity-related capital to small and emerging health care companies.Tullis focuses on companies that have already established operations or have completed a substantial portion of their development process for new products, technologies and services. Many Tullis companies have generated meaningful revenue and require capital in order to reach value-enhancing milestones in a defined two- to four-year period. Others are research and development stage medical companies which have passed key milestones, but require additional capital to achieve commercial status.